128 related articles for article (PubMed ID: 6800691)
1. Levonorgestrel in milk and plasma of breast-feeding women with a levonorgestrel-releasing IUD.
Heikkilä M; Haukkamaa M; Luukkainen T
Contraception; 1982 Jan; 25(1):41-9. PubMed ID: 6800691
[TBL] [Abstract][Full Text] [Related]
2. Duration of breast-feeding and development of children after insertion of a levonorgestrel-releasing intrauterine contraceptive device.
Heikkilä M; Luukkainen T
Contraception; 1982 Mar; 25(3):279-92. PubMed ID: 6804164
[TBL] [Abstract][Full Text] [Related]
3. Sustained intrauterine release of levonorgestrel over five years.
Nilsson CG; Lahteenmaki PL; Luukkainen T; Robertson DN
Fertil Steril; 1986 Jun; 45(6):805-7. PubMed ID: 3086130
[TBL] [Abstract][Full Text] [Related]
4. Puerperal insertion of a copper-releasing and a levonorgestrel-releasing intrauterine contraceptive device.
Heikkilä M
Contraception; 1982 Jun; 25(6):561-72. PubMed ID: 6811195
[TBL] [Abstract][Full Text] [Related]
5. Levonorgestrel plasma concentrations and hormone profiles after insertion and after one year of treatment with a levonorgestrel-IUD.
Nilsson CG; Lähteenmäki P; Luukkainen T
Contraception; 1980 Mar; 21(3):225-33. PubMed ID: 6771090
[TBL] [Abstract][Full Text] [Related]
6. d-Norgestrel concentrations in maternal plasma, milk, and child plasma during administration of oral contraceptives to nursing women.
Nilsson S; Nygren KG; Johansson ED
Am J Obstet Gynecol; 1977 Sep; 129(2):178-84. PubMed ID: 900181
[TBL] [Abstract][Full Text] [Related]
7. Acceptability of an experimental intracervical device: results of a study controlling for selection bias.
Shain RN; Ratsula K; Toivonen J; Lähteenmäki P; Luukkainen T; Holden AE; Rosenthal M
Contraception; 1989 Jan; 39(1):73-84. PubMed ID: 2491982
[TBL] [Abstract][Full Text] [Related]
8. Effective contraception with the levonorgestrel-releasing intrauterine device: 12-month report of a European multicenter study.
Luukkainen T; Allonen H; Haukkamaa M; Holma P; Pyörälä T; Terho J; Toivonen J; Batar I; Lampe L; Andersson K
Contraception; 1987 Aug; 36(2):169-79. PubMed ID: 3123132
[TBL] [Abstract][Full Text] [Related]
9. Intracervical release of levonorgestrel for contraception.
Kurunmäki H; Toivonen J; Lähteenmäki P; Luukkainen T
Contraception; 1981 May; 23(5):473-85. PubMed ID: 6793299
[TBL] [Abstract][Full Text] [Related]
10. Plasma concentrations of levonorgestrel as a function of the release rate of levonorgestrel from medicated intra-uterine devices.
Nilsson CG; Lähteenmäki P; Robertson DN; Luukkainen T
Acta Endocrinol (Copenh); 1980 Mar; 93(3):380-4. PubMed ID: 7376797
[TBL] [Abstract][Full Text] [Related]
11. Fertility after discontinuation of levonorgestrel-releasing intrauterine devices.
Nilsson CG
Contraception; 1982 Mar; 25(3):273-8. PubMed ID: 6804163
[TBL] [Abstract][Full Text] [Related]
12. ICMR task force study on hormonal contraception. Transfer of levonorgestrel (LNG) administered through different drug delivery systems from the maternal circulation into the newborn infant's circulation via breast milk.
Shikary ZK; Betrabet SS; Patel ZM; Patel S; Joshi JV; Toddywala VS; Toddywala SP; Patel DM; Jhaveri K; Saxena BN
Contraception; 1987 May; 35(5):477-86. PubMed ID: 3113823
[TBL] [Abstract][Full Text] [Related]
13. Two years of intrauterine contraception with levonorgestrel and with copper: a randomized comparison of the TCu 380Ag and levonorgestrel 20 mcg/day devices.
Sivin I; Stern J; Diaz J; Diaz MM; Faundes A; el Mahgoub S; Diaz S; Pavez M; Coutinho E; Mattos CE
Contraception; 1987 Mar; 35(3):245-55. PubMed ID: 3111785
[TBL] [Abstract][Full Text] [Related]
14. Long-term contraception with the levonorgestrel 20 mcg/day (LNg 20) and the copper T 380Ag intrauterine devices: a five-year randomized study.
Sivin I; el Mahgoub S; McCarthy T; Mishell DR; Shoupe D; Alvarez F; Brache V; Jimenez E; Diaz J; Faundes A
Contraception; 1990 Oct; 42(4):361-78. PubMed ID: 2124179
[TBL] [Abstract][Full Text] [Related]
15. Patterns of ovulation and bleeding with a low levonorgestrel-releasing intrauterine device.
Nilsson CG; Lähteenmäki P; Luukkainen T
Contraception; 1980 Feb; 21(2):155-64. PubMed ID: 6768490
[TBL] [Abstract][Full Text] [Related]
16. Plasma levonorgestrel levels and ovarian function during the use of a levonorgestrel-releasing intracervical contraceptive device.
Ratsula K; Toivonen J; Lähteenmäki P; Luukkainen T
Contraception; 1989 Feb; 39(2):195-204. PubMed ID: 2495893
[TBL] [Abstract][Full Text] [Related]
17. Two years' experience with two levonorgestrel-releasing intrauterine devices and one copper-releasing intrauterine device: a randomized comparative performance study.
Nilsson CG; Allonen H; Diaz J; Luukkainen T
Fertil Steril; 1983 Feb; 39(2):187-92. PubMed ID: 6401636
[TBL] [Abstract][Full Text] [Related]
18. The detection and measurement of D-norgestrel in human milk using Sephadex LH 20 chromatography and radioimmunoassay.
Thomas MJ; Danutra V; Read GF; Hillier SG; Griffiths K
Steroids; 1977 Sep; 30(3):349-61. PubMed ID: 595034
[TBL] [Abstract][Full Text] [Related]
19. Five years' experience with levonorgestrel-releasing IUDs.
Luukkainen T; Allonen H; Haukkamaa M; Lähteenmäki P; Nilsson CG; Toivonen J
Contraception; 1986 Feb; 33(2):139-48. PubMed ID: 3084167
[TBL] [Abstract][Full Text] [Related]
20. [The role of copper-releasing intrauterine device or levonorgestrel-releasing intrauterine system on uterine bleeding and iron status (prospective study of 8 years)].
Imperato F; Perniola G; Mossa B; Marziani R; Perniola F; Stragapede B; Napolitano C
Minerva Ginecol; 2002 Jun; 54(3):271-8. PubMed ID: 12063443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
